# A Study of SYNT001 in Healthy Volunteers

> **NCT03643627** · EARLY_PHASE1 · COMPLETED · sponsor: **Syntimmune, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** SYNT001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03643627
- **Lead sponsor:** Syntimmune, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-17
- **Primary completion:** 2017-04-13
- **Final completion:** 2017-04-13
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643627, "A Study of SYNT001 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03643627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*